Skip to content

Category: Top Stories

Stocks making the biggest moves midday: Netflix, Coinbase, Diageo, Cava and more

Business Men Break Sit Read Newspaper

These are some of the stocks posting the largest moves in midday trading.

Anthropic goes from software foe to friend. These stocks should benefit

Business Men Break Sit Read Newspaper

Anthropic positioned its products as additive, rather than threatening, to existing software providers, analysts said.

Are collectibles a viable asset class? The buyer of the $16.5 million Pokémon card thinks so

Business Men Break Sit Read Newspaper

AJ Scaramucci thinks trading cards have experienced tremendous growth, and thus they, and other collectibles, are great alternative investments.

Epstein files: Nobel winner Axel quits Columbia U. brain institute over friendship with predator

Business Men Break Sit Read Newspaper

Dr. Richard Axel, a longtime Columbia University professor, is mentioned repeatedly in the Jeffrey Epstein files released by the Department of Justice.

Nvidia set to report quarterly results after the bell

Business Men Break Sit Read Newspaper

Nvidia has been the best performer on Wall Street this year among tech’s megacap companies.

Bill Gates addresses Epstein files in candid town hall days after last-minute speaking cancellation

Business Men Break Sit Read Newspaper

Bill Gates “took responsibility for his actions” in a meeting with employees of the Gates Foundation, which had held fundraising discussions with Epstein.

Epstein files: Larry Summers to resign as Harvard professor

Business Men Break Sit Read Newspaper

Post Content

Analysts see a turnaround for this unique e-commerce play after a unit sale and strong earnings

Business Men Break Sit Read Newspaper

This is “one of the top five most visited websites, more than a lot of household names,” one analyst said.

Normally staid bond investors have a new biggest worry: An AI bubble

Business Men Break Sit Read Newspaper

Investors expect a surge in bond issuance from hyperscalers, according to a new survey.

Direct-to-consumer sales for obesity drugs are about to boom. JPMorgan sees Eli Lilly as big winner

Business Men Break Sit Read Newspaper

Thanks to its “best-in-class” status, the bank believes the company will be the winner from a growing GLP-1 patient base.

← Previous
Next →

Ready to take your stock trading to the next level? Sign up now to receive exclusive market analyses, insightful tips, and valuable resources straight to your inbox. Don’t miss out on the opportunity to stay ahead in the ever-evolving world of trading!

JOIN OUR COMMUNITY

Join our growing community of educated investors working together to build wealth with a diversified outlook at investment opportunities

Copyright © 2023. All Rights Reserved.

  • Privacy & Policy
  • Disclaimer